Yunlong Wang
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients (NCT07715929) | Yunlong Wang | 2026-09-01 |
| Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF (NCT07630454) | Yunlong Wang | 2026-08-01 |
| The COMBINE-AF Trial (NCT07633509) | Yunlong Wang | 2026-07-27 |
Track Yunlong Wang automatically
Every clearance here is in the API, with alerts when new ones post.